BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15540922)

  • 21. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea].
    Tokuda K
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
    Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea and low dose rate radiation in the 9L rat brain tumor and spheroid models: implications for brain tumor brachytherapy.
    Gutin PH; Bernstein M; Sano Y; Deen DF
    Neurosurgery; 1984 Dec; 15(6):781-6. PubMed ID: 6514150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of stable phenotypes from 9L rat brain tumor multicellular spheroids treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Barcellos-Hoff MH; Linfoot PA; Marton LJ; Deen DF
    Int J Cancer; 1992 Sep; 52(3):409-13. PubMed ID: 1399117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Hung DT; Deen DF; Seidenfeld J; Marton LJ
    Cancer Res; 1981 Jul; 41(7):2783-5. PubMed ID: 6788362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
    Winter PM; Poptani H; Bansal N
    Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
    Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
    J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.
    Schepkin VD; Lee KC; Kuszpit K; Muthuswami M; Johnson TD; Chenevert TL; Rehemtulla A; Ross BD
    NMR Biomed; 2006 Dec; 19(8):1035-42. PubMed ID: 16894643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT; Lee S; Yin GN; Mori K; Suk K
    J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model.
    Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
    DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
    J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
    Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
    J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
    J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the effects of hyperthermia and BCNU on BCNU-sensitive and BCNU-resistant 9L rat brain tumor cells.
    Da Silva V; Tofilon PJ; Gutin PH; Dewey WC; Buckley N; Deen DF
    Radiat Res; 1985 Sep; 103(3):363-72. PubMed ID: 4034932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
    Hunter KJ; Deen DF; Pellarin M; Marton LJ
    Cancer Res; 1990 May; 50(9):2769-72. PubMed ID: 2109657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
    Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
    Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
    J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.